Home › Merck to buy Idenix Pharma for $3.85 billion
 

Keywords :   


Merck to buy Idenix Pharma for $3.85 billion

2014-06-09 15:33:35| Biotech - Topix.net

Merck & Co. says the Cambridge, Massachusetts, company has built a promising portfolio of hepatitis C treatments, including three in clinical testing Merck will spend $24.50 per share in cash for each share, which closed at $7.23 Friday.

Tags: buy billion pharma merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09Tropical Storm John Update Statement
23.09Summary for Tropical Storm John (EP5/EP102024)
23.09Is the Budget's bite going to be rather less painful than its bark?
23.09Flushability Standard Introduced in China
23.09Union boss questions Amazon public contracts
23.09Texas Landowners Advocate for Major Changes to Oilfield Waste Disposal Procedures
23.09Long Islands Waste Future Uncertain as Landfill Closure Looms
23.09Mortgages at six times' income for first-time buyers
More »